Table 1.

The therapeutic effect of VitA on several infantile infectious diseases.

Diseases	Role of VitA	Method Setting	Model [Reference]
Measles	Reduce mortality	Meta-analysis	Human [138]
Measles	Reduce morbidity and mortality	Systematic review and meta-analysis	Human [129]
Measles	Reduce mortality	Meta-analysis	Human [139]
Measles	Reduce morbidity	Randomized double-blind controlled trial	Human [140]
Acute pneumonia	Promoting the production of specific antibodies	Randomized controlled trial	Mice [141]
Acute pneumonia	Relieving clinical symptoms and signs	Meta-analysis	Human [128]
Infantile diarrhea	Reduce morbidity and mortality	Systematic review and meta-analysis	Human [129]
Infantile diarrhea	Promote the production of IgA in the intestinal tract and enhance the mucosal immune function	Randomized controlled trial	Mice [142]
Infantile diarrhea	Reduce morbidity	Randomized double-blind controlled trial	Human [140]
Enteric infection	Reduce morbidity and mortality	Randomized controlled trial	Mice [143]
Malaria	Reduce morbidity	Randomized double-blind controlled trial	Human [144]
Malaria	Reduce morbidity	Randomized controlled trial	Human [145]
Malaria	Reduce morbidity	Randomized double-blind controlled trial	Human [146]
Hand foot and mouth disease	Promote production of immunoglobulin and enhance antiviral function	Cross-sectional observation and study	Human [130]
Mumps	Up-regulation of type 1 interferon and inhibition of viral replication	In vitro controlled experiment	Cells [147]